Carina Boros, Olivier Sutter, François Cauchy, Nathalie Ganne-Carrié, Pierre Nahon, Gisele N'kontchou, Marianne Ziol, Véronique Grando, Alix Demory, Lorraine Blaise, Fédérica Dondero, François Durand, Olivier Soubrane, Mickael Lesurtel, Alexis Laurent, Oliver Seror, Jean Charles Nault
INTRODUCTION: We aim to assess the long-term outcomes of percutaneous multi-bipolar radiofrequency (mbpRFA) as the first treatment for hepatocellular carcinoma (HCC) in transplant-eligible cirrhotic patients, followed by salvage transplantation for intrahepatic distant tumour recurrence or liver failure. MATERIALS AND METHODS: We included transplant-eligible patients with cirrhosis and a first diagnosis of HCC within Milan criteria treated by upfront mbp RFA. Transplantability was defined by age <70 years, social support, absence of significant comorbidities, no active alcohol use and no recent extrahepatic cancer...
April 6, 2024: Liver International: Official Journal of the International Association for the Study of the Liver